Literature DB >> 2990630

Rh(D) haemolytic disease of the newborn: the changing scene.

S J Urbaniak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990630      PMCID: PMC1416181          DOI: 10.1136/bmj.291.6487.4

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  14 in total

1.  Prevention of Rh haemolytic disease.

Authors:  L A Tovey; J Murray; B J Stevenson; J M Taverner
Journal:  Br Med J       Date:  1978-07-08

2.  Production of human monoclonal antibody to rhesus D antigen.

Authors:  D H Crawford; M J Barlow; J F Harrison; L Winger; E R Huehns
Journal:  Lancet       Date:  1983-02-19       Impact factor: 79.321

3.  Should anti-D immunoglobulin be given antenatally?

Authors:  G H Tovey
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

4.  Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.

Authors:  P Bowell; J S Wainscoat; T E Peto; H H Gunson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

5.  Fetal blood group studies during mid-trimester pregnancy and the management of severe isoimmunization.

Authors:  I MacKenzie; C M Guest; P J Bowell
Journal:  Prenat Diagn       Date:  1983-01       Impact factor: 3.050

6.  A case for the antenatal administration of anti-D immunoglobulin to primigravidae.

Authors:  L A Tovey; J M Taverner
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

7.  Intrauterine fetal transfusions: Winnipeg 1982.

Authors:  J M Bowman; F A Manning
Journal:  Obstet Gynecol       Date:  1983-02       Impact factor: 7.661

8.  Continuous-flow plasmapheresis in management of severe rhesus disease.

Authors:  J Graham-Pole; W Barr; M L Willoughby
Journal:  Br Med J       Date:  1977-05-07

9.  The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.

Authors:  L A Tovey; A Townley; B J Stevenson; J Taverner
Journal:  Lancet       Date:  1983-07-30       Impact factor: 79.321

10.  Intensive plasma exchange in the management of severe Rh disease.

Authors:  E Angela; E Robinson; L A Tovey
Journal:  Br J Haematol       Date:  1980-08       Impact factor: 6.998

View more
  2 in total

1.  Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage lambda vectors.

Authors:  R A Williamson; M A Persson; D R Burton
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

2.  The experience and effectiveness of the Nova Scotia Rh program, 1964-84.

Authors:  T F Baskett; M L Parsons; L J Peddle
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.